TY - JOUR
T1 - Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in late sepsis
AU - Nwafor, Divine C.
AU - Chakraborty, Sreeparna
AU - Brichacek, Allison L.
AU - Jun, Sujung
AU - Gambill, Catheryne A.
AU - Wang, Wei
AU - Engler-Chiurazzi, Elizabeth B.
AU - Dakhlallah, Duaa
AU - Pinkerton, Anthony B.
AU - Millán, José Luis
AU - Benkovic, Stanley A.
AU - Brown, Candice M.
N1 - Funding Information:
The authors gratefully thank Jessica Povroznik, M.S. for her technical support and assistance with rodent behavioral training. We acknowledge the technical support from Dr. Kathleen Brundage in the West Virginia University Flow Cytometry and Single Cell Core Facility, which is supported by the National Institutes of Health (NIH) equipment grant number S10 OD016165 and the Institutional Development Awards (IDeA) from the National General Medical Sciences of the National Institutes of Health under grant numbers P30 GM103488 (Cancer CoBRE) and P20 GM103434 (INBRE). Funding for this work was supported by the NIH T32 AG052375 (D.C.N, A.L.B), K01 NS081014 (C.M.B), West Virginia Clinical and Translational Science Institute ( U54 GM104942 ), and the West Virginia University Stroke CoBRE ( P20 GM109098 ). Appendix A
Funding Information:
The authors gratefully thank Jessica Povroznik, M.S. for her technical support and assistance with rodent behavioral training. We acknowledge the technical support from Dr. Kathleen Brundage in the West Virginia University Flow Cytometry and Single Cell Core Facility, which is supported by the National Institutes of Health (NIH) equipment grant number S10 OD016165 and the Institutional Development Awards (IDeA) from the National General Medical Sciences of the National Institutes of Health under grant numbers P30 GM103488 (Cancer CoBRE) and P20 GM103434 (INBRE). Funding for this work was supported by the NIH T32 AG052375 (D.C.N, A.L.B), K01 NS081014 (C.M.B), West Virginia Clinical and Translational Science Institute (U54 GM104942), and the West Virginia University Stroke CoBRE (P20 GM109098).
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2020/2
Y1 - 2020/2
N2 - Sepsis is a host response to systemic inflammation and infection that may lead to multi-organ dysfunction and eventual death. While acute brain dysfunction is common among all sepsis patients, chronic neurological impairment is prevalent among sepsis survivors. The brain microvasculature has emerged as a major determinant of sepsis-associated brain dysfunction, yet the mechanisms that underlie its associated neuroimmune perturbations and behavioral deficits are not well understood. An emerging body of data suggests that inhibition of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels may be associated with changes in endothelial cell barrier integrity. The objective of this study was to elucidate the connection between alterations in cerebrovascular TNAP enzyme activity and brain microvascular dysfunction in late sepsis. We hypothesized that the disruption of TNAP enzymatic activity in cerebral microvessels would be coupled to the sustained loss of brain microvascular integrity, elevated neuroinflammatory responses, and behavioral deficits. Male mice were subjected to cecal ligation and puncture (CLP), a model of experimental sepsis, and assessed up to seven days post-sepsis. All mice were observed daily for sickness behavior and underwent behavioral testing. Our results showed a significant decrease in brain microvascular TNAP enzyme activity in the somatosensory cortex and spinal cord of septic mice but not in the CA1 and CA3 hippocampal regions. Furthermore, we showed that loss of cerebrovascular TNAP enzyme activity was coupled to a loss of claudin-5 and increased perivascular IgG infiltration in the somatosensory cortex. Analyses of whole brain myeloid and T-lymphoid cell populations also revealed a persistent elevation of infiltrating leukocytes, which included both neutrophil and monocyte myeloid derived suppressor cells (MDSCs). Regional analyses of the somatosensory cortex, hippocampus, and spinal cord revealed significant astrogliosis and microgliosis in the cortex and spinal cord of septic mice that was accompanied by significant microgliosis in the CA1 and CA3 hippocampal regions. Assessment of behavioral deficits revealed no changes in learning and memory or evoked locomotion. However, the hot plate test uncovered a novel anti-nociceptive phenotype in our septic mice, and we speculate that this phenotype may be a consequence of sustained GFAP astrogliosis and loss of TNAP activity in the somatosensory cortex and spinal cord of septic mice. Taken together, these results demonstrate that the loss of TNAP enzyme activity in cerebral microvessels during late sepsis is coupled to sustained neuroimmune dysfunction which may underlie, in part, the chronic neurological impairments observed in sepsis survivors.
AB - Sepsis is a host response to systemic inflammation and infection that may lead to multi-organ dysfunction and eventual death. While acute brain dysfunction is common among all sepsis patients, chronic neurological impairment is prevalent among sepsis survivors. The brain microvasculature has emerged as a major determinant of sepsis-associated brain dysfunction, yet the mechanisms that underlie its associated neuroimmune perturbations and behavioral deficits are not well understood. An emerging body of data suggests that inhibition of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels may be associated with changes in endothelial cell barrier integrity. The objective of this study was to elucidate the connection between alterations in cerebrovascular TNAP enzyme activity and brain microvascular dysfunction in late sepsis. We hypothesized that the disruption of TNAP enzymatic activity in cerebral microvessels would be coupled to the sustained loss of brain microvascular integrity, elevated neuroinflammatory responses, and behavioral deficits. Male mice were subjected to cecal ligation and puncture (CLP), a model of experimental sepsis, and assessed up to seven days post-sepsis. All mice were observed daily for sickness behavior and underwent behavioral testing. Our results showed a significant decrease in brain microvascular TNAP enzyme activity in the somatosensory cortex and spinal cord of septic mice but not in the CA1 and CA3 hippocampal regions. Furthermore, we showed that loss of cerebrovascular TNAP enzyme activity was coupled to a loss of claudin-5 and increased perivascular IgG infiltration in the somatosensory cortex. Analyses of whole brain myeloid and T-lymphoid cell populations also revealed a persistent elevation of infiltrating leukocytes, which included both neutrophil and monocyte myeloid derived suppressor cells (MDSCs). Regional analyses of the somatosensory cortex, hippocampus, and spinal cord revealed significant astrogliosis and microgliosis in the cortex and spinal cord of septic mice that was accompanied by significant microgliosis in the CA1 and CA3 hippocampal regions. Assessment of behavioral deficits revealed no changes in learning and memory or evoked locomotion. However, the hot plate test uncovered a novel anti-nociceptive phenotype in our septic mice, and we speculate that this phenotype may be a consequence of sustained GFAP astrogliosis and loss of TNAP activity in the somatosensory cortex and spinal cord of septic mice. Taken together, these results demonstrate that the loss of TNAP enzyme activity in cerebral microvessels during late sepsis is coupled to sustained neuroimmune dysfunction which may underlie, in part, the chronic neurological impairments observed in sepsis survivors.
KW - Astrogliosis
KW - Blood–brain barrier
KW - Cecal ligation and puncture
KW - Microgliosis
KW - Neuroimmune
KW - Nociception
KW - Sepsis
KW - Tissue non-specific alkaline phosphatase
UR - http://www.scopus.com/inward/record.url?scp=85076493394&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076493394&partnerID=8YFLogxK
U2 - 10.1016/j.bbi.2019.11.016
DO - 10.1016/j.bbi.2019.11.016
M3 - Article
C2 - 31778743
AN - SCOPUS:85076493394
SN - 0889-1591
VL - 84
SP - 115
EP - 131
JO - Brain, Behavior, and Immunity
JF - Brain, Behavior, and Immunity
ER -